Intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 41, Issue 6, 2007, Pages 326-328

  Hasegawa, Toshio ^a   Suga, Yasushi ^a   Mizoguchi, Masayuki ^a   Muramatsu, Shigenori ^a   Mizuno, Yuki ^a   Haruna, Kunitaka ^a   Ikeda, Shigaku ^a   Kuroyanagi, Yoshimitsu ^b   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Cultured dermal substitute; Venous ulcer

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; ARTIFICIAL SKIN; CASE REPORT; CELL CULTURE; DEBRIDEMENT; GRANULATION TISSUE; HUMAN; MALE; MIDDLE AGED; VARICOSIS;

CELLS, CULTURED; DEBRIDEMENT; GRANULATION TISSUE; HUMANS; MALE; MIDDLE AGED; SKIN, ARTIFICIAL; TRANSPLANTATION, HOMOLOGOUS; VARICOSE ULCER;

EID: 36048980864     PISSN: 02844311     EISSN: 16512073     Source Type: Journal    
DOI: 10.1080/02844310600723224     Document Type: Article

References (10)

1. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin deposition in the ulcer bearing skin of the lower limb: the cause of lipodermatosclerosis and venous ulceration. BMJ 1982;285:1071-2.
2. Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs 2004;28:444-50.
3. Hasegawa T, Suga Y, Mizoguchi M, et al. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004;50:803-4.
4. Ohtani T, Okamoto K, Kaminaka C, et al. Digital gangrene associated with idiopathic hypereosinophilia; treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004;14:168-71.
5. Moroi Y, Fujita S, Fukagawa S, et al. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol 2004;14:172-6.
6. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998;134: 293-300.
7. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts; fundamental evaluation. J Biomater Sci Polym Ed 2003;14:625-11.
8. Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. Artif Organs 2003;6:138-14.
9. Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. Artif Organs 2003;6:267-72.
10. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation. Artif Organs 2004;28:182-8.